LGALS3BP and neoplasm: In the present study, we confirm and extend these findings by showing that LGALS3BP knock-down human CRC cells formed large tumors when implanted in nude mice and that intra-tumor delivery of human recombinant LGALS3BP induced regression of established CRC xenografts.